The purported change in ownership was allegedly related to a significant discontinuance of a significant business segment, i.e. the pharmaceutical business of GSK Bangladesh. This is considered misleading.”Minority shareholders have 18 per cent stakes in GSK Bangladesh. The BSEC also raised issues about GSK Bangladesh’s name change to Unilever Consumer Care in July. The company disclosed nothing about the underlying intangibles of GSK Bangladesh, it said.

Source: Dhaka Tribune November 23, 2020 20:12 UTC